---
layout: single
author_profile: false
classes: wide

title: "CSL Behring: Future direction of plasma therapy industry"
header:
#  image: /assets/images/mgt/csl_behring.jpg
  teaser: /assets/images/mgt/csl_behring-th.png
  og_image: /assets/images/unsplash-image.jpg
images_gallery:
  - url: /assets/images/mgt/csl_behring.jpg
    image_path: /assets/images/mgt/csl_behring.jpg
sidebar:
  - title: "Organization"
    text: "UCA"
  - title: "Role"
    text: "Senior Consultant"
  - title: "Responsibilities"
    text: "Supporting UCA project team at UNIST, Co-working with UIUC" 
  - title: "Period"
    text: "Jan.2021 - Jun.2021"
  - title: "Location"
    text: "Ulsan, Korea & Chicago, IL, US" 
---

Explorative project on plasma therapy and its application after covid-19 era. 

{% include gallery id="images_gallery" %}

The project is conducted by UCA (UNIST Consulting Association) (at UNIST) and supported by Prof. Yoo-Seong Song at UIUC. The purpose of the project is to understand the industry pipeline of plasma therapy and its application after the covid-19 era. The project consists of an analysis of multiple pieces of research and domain expert interviews. 

&#10003;  <a href=https://www.cslbehring.com/vita/2020/taking-plasma-treatment-to-the-next-level-with-a-hyperimmune" class="no-uline"> CSL Behring: Taking Plasma Treatment to the Next Level</a>

This project is a part of UCA, which is a student-run, global consultancy that bridges interdisciplinary gaps to connect students to technology and entrepreneurial companies, creating international networks for lifelong bonds. 

Under the NDA, detailed information of the project is not described in this article.